Four new autoantigens trigger multiple sclerosisSwiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice. more ➔
TWB partners with Processium and SyngulonIndustrial biotech project managment specialist Toulouse White Biotech (TWB) has joined forces with process developer Processium and industrial synbio start-up Syngulon. more ➔
Meat consumption must fall by at least 75 percentIf our planet is to continue feeding us in the future, rich countries must significantly reduce their meat consumption by at least 75% suggests a new study by German researchers. more ➔
Vigeneron updates gene therapy collab with Daiichi SankyoViGeneron and Daiichi Sankyo have agreed a follow-on collaboration to evaluate vgAAVs as vectors for Daiichi Sankyo’ novel treatment of prevalent eye diseases. more ➔
Single-use market to reach $20.8bn by 2026 Analysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product. more ➔
Study shows advantages of cellular agricultureNovel foods derived from cell culture instead of animals reduce the environmental impact of diets, water and land use by 80%, report Finnish researchers. more ➔
EMA delays Valneva vaccine approvalThe approval of Valneva’s Corona vaccine is delaying. The European Medicines Agency’s CHMP requested additional data. more ➔
Mimetas BV participating in €325m cancer fundingOrgan-on-chip disease model specialist Mimentas BV participates in a €325m funding to accelerate preclinical cancer R&D in the Netherlands. more ➔
Hansa Biopharma’s imlifidase advances to Phase III testingThe US Food & Drug Administration has given the green light for Phase III testing of Hansa Biopharma’s imlifidase in anti-GBM disease. more ➔
GSK acquires Sierra Oncology for 1.9bnGlaxoSmithKline acquires California-based Sierra Oncology and a ready-for-approval product candidate for myelofibrosis. more ➔
